UNITY Biotechnology to Participate in Upcoming March Investor Conferences
February 26 2021 - 4:05PM
UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology
company developing therapeutics to slow, halt or reverse diseases
of aging, today announced that members of its senior management
team will participate in the following upcoming March virtual
investor conferences:
Cowen 41st
Annual Healthcare Conference Date: March 3,
2021Presentation Time: 1:20 p.m. ET
33rd Annual ROTH
ConferenceDate: March 15, 2021Presentation Time: 4:00 p.m.
ET
A live audio webcast of the presentations will
be available through the Investors & Media section of UNITY’s
website. An archived replay will be available for 90 days following
each event.
About UNITYUNITY is developing a new class of
therapeutics to slow, halt or reverse diseases of aging. UNITY’s
current focus is on creating medicines to selectively eliminate or
modulate senescent cells and thereby provide transformative benefit
in age-related ophthalmologic and neurologic diseases.
More information is available
at www.unitybiotechnology.com or follow us
on Twitter and LinkedIn.
Investors
Gilmartin Group
Matt Lane
ir@unitybiotechnology.com
Media
Canale Communications
Jason Spark
Jason.spark@canalecomm.com
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Mar 2024 to Apr 2024
UNITY Biotechnology (NASDAQ:UBX)
Historical Stock Chart
From Apr 2023 to Apr 2024